NCT04088175View on ClinicalTrials.gov

Study to Characterize Puffing Topography With Use of JUUL Electronic Nicotine Delivery Systems (ENDS) in Adult, Closed-System ENDS Consumers

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

October 28, 2019

Primary Completion Date

January 23, 2020

Study Completion Date

January 23, 2020

Conditions
Electronic Cigarette Use
Interventions
OTHER

JUUL ENDS - Virginia Tobacco 5% nicotine strength

JUUL ENDS - Virginia Tobacco 5% nicotine strength

OTHER

JUUL ENDS - Virginia Tobacco 3% nicotine strength

JUUL ENDS - Virginia Tobacco 3% nicotine strength

OTHER

JUUL ENDS - Menthol 5% nicotine strength

JUUL ENDS - Menthol 5% nicotine strength

OTHER

JUUL ENDS - Menthol 3% nicotine strength

JUUL ENDS - Menthol 3% nicotine strength

OTHER

JUUL ENDS - Mint 5% nicotine strength

JUUL ENDS - Mint 5% nicotine strength

OTHER

JUUL ENDS - Mint 3% nicotine strength

JUUL ENDS - Mint 3% nicotine strength

OTHER

JUUL ENDS - Mango 5% nicotine strength

JUUL ENDS - Mango 5% nicotine strength

OTHER

JUUL ENDS - Mango 3% nicotine strength

JUUL ENDS - Mango 3% nicotine strength

Trial Locations (2)

21209

Battelle Public Health Lab, Baltimore

91505

Los Angeles Clinical Trials, Burbank

Sponsors
All Listed Sponsors
collaborator

Los Angeles Clinical Trials

UNKNOWN

collaborator

Battelle Memorial Institute

OTHER

lead

Juul Labs, Inc.

INDUSTRY

NCT04088175 - Study to Characterize Puffing Topography With Use of JUUL Electronic Nicotine Delivery Systems (ENDS) in Adult, Closed-System ENDS Consumers | Biotech Hunter | Biotech Hunter